STM publisher Elsevier has announced that The European Society for Blood and Marrow Transplantation (EBMT), a non-profit organisation established to fight life-threatening blood cancers and diseases, will implement Elsevier's MACRO platform to support its vital and long-standing patient registry.
The EBMT identified a need to evolve its registry to ensure that it is fit for the current treatment and patient landscape, while also supporting the introduction of new treatment technologies, along with subsequent technical, legal and medical requirements.
This registry update, named Project 2020, will result in a platform that is more intuitive and user-friendly, is truly collaborative and increases efficiency of data collection and retrieval, resulting in increased scope and quality of the data available.
Elsevier's MACRO is a powerful, industry-standard electronic data capture solution that has been proven in commercial and not-for-profit clinical research since 1999. MACRO's dynamic and easy to use tools for study definition, data capture and data management simplify set-up, reduce time to first data entry and to database lock, and help researchers succeed every time in increasingly complex clinical trials. MACRO is used by pharmaceutical companies, academic medical centres, CROs and medical device companies.
Project 2020 is a priority for the continued success of EBMT. The flexibility of MACRO, along with its user-focused interface and in-built data management and quality control processes, ensures that the updated registry will continue to drive high-level research and education.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
